Cardiac resynchronization therapy devices: Patient management and follow-up strategies

Reviews in Cardiovascular Medicine

Volumn 4, Issue SUPPL. 2, 2003, Pages

  Leon, Angel R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac dyssynchrony; Cardiac resynchronization; Congestive heart failure; Echocardiographjy; Tissue Doppler imaging

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; SPIRONOLACTONE; WARFARIN;

ARTIFICIAL HEART PACEMAKER; CARDIOLOGY; CLINICAL TRIAL; DEFIBRILLATOR; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FOLLOW UP; HEART DISEASE; HEART FAILURE; HUMAN; IMPLANTATION; MEDICAL INSTRUMENTATION; MEDICAL SPECIALIST; PATIENT REFERRAL; PATIENT SELECTION; PHYSICIAN; PRIMARY MEDICAL CARE; REVIEW; SYMPTOMATOLOGY; TREATMENT PLANNING; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; EQUIPMENT; HEART PACING; HOSPITALIZATION; METHODOLOGY; PATHOLOGY; PATIENT CARE;

CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EQUIPMENT FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT CARE TEAM; SEVERITY OF ILLNESS INDEX;

EID: 0037502600     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Abraham WT, Fisher WG, Smith AL, et al. for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
2. Cazeau S, Leclercq C, Lavergne T, et al. for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-880.
3. Auricchio A, Stellbrink C, Sack S, et al. for the Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026-2033.
4. Bristow MR. Late-breaking clinical trials. Presented at: American College of Cardiology 52nd Annual Scientific Session; March 30-April 2, 2003; Chicago, IL.
5. Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail. 2001;3:481-489.
6. Sogaard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization. J Am Coll Cardiol. 2002;40:723-730.
7. Yu CM, Fung WH, Lin H, et al. Predicators of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 2003;91:684-688.
8. Hunnicutt D, Smith A, Leon AR, Langberg JL. Experience with cardiac resynchronization therapy in patients requiring inotropic support. Accepted for presentation at: North American Society of Pacing and Electrophysiology 24th Annual Scientific Sessions; May 14-17, 2003; Washington, DC.
9. Moss AJ, Zareba W, Hall J, et al, for the Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
10. Greenberg JM, Mera F, DeLurgio DB, et al. Safety of implantation of cardiac resynchronization devices: a review of major biventricular pacing trials. To be presented at: North American Society of Pacing and Electrophysiology 24th Annual Scientific Sessions; May 14-17, 2003; Washington, DC.
11. DeLurgio DB, Chinchoy E, Ransom SA, et al. Stability of the optimal right ventricular to left ventricular timing sequence during biventricular pacing for congestive heart failure as determined by Doppler-derived stroke volume. Presented at: North American Society of Pacing and Electrophysiology 23rd Annual Scientific Sessions; May 8-11, 2002; San Diego, CA.
12. Data on file. Premarket approval P010012. Indianapolis, IN: Guidant Corporation. Available at: http://www.fda.gov/cdrh/pdf/P0100126.pdf. Accessed April 24, 2003.
13. Leon AR. Effect of cardiac resynchronization therapy with sequential biventricular pacing on Doppler derived left ventricular stroke volume, functional status and exercise capacity in patients with ventricular dysfunction and conduction delay: the US InSync-III Trial. Presented at: North American Society of Pacing and Electrophysiology 23rd Annual Scientific Sessions; May 8-11, 2002; San Diego, CA.